Dry Eye Disease Diagnostics &
Treatment Market: Introduction
According to the report, the global dry eye disease diagnostics &
treatment market was valued at US$ 6.1 Bn in 2019 and
is projected to expand at a CAGR of ~4% from 2020 to 2030.
Dry eye is one of the common problems, which occurs when eyes do not produce
enough tears. Several factors can cause dry eyes such as natural aging process
and side effects of certain drugs such as histamines. Diabetes increases the
risk of dry eye disease. Moreover, people who wear contact lenses complain of
dry eye diseases. Dry eye is caused due to tear deficiency or excessive
evaporation, which causes damage to the interpalpebral ocular surface and is
associated with symptoms of ocular discomfort. Different diagnostic tests are
performed for diagnosis of dry eye disease such as Schirmer’s test, corneal
staining, and tear osmolarity. Treatment options for dry eye include artificial
tears, anti-inflammatory drugs, and secretagogue.
North America dominated the global dry eye disease diagnostics
& treatment market in 2019. It is expected to dominate the global market
in terms of revenue during the forecast period.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78437
Rise in Prevalence & Incidence
Rates of Dry Eye Disease and Increase in Geriatric Population to Drive Global
Market
Rise in prevalence & incidence rates of dry eye disease and
increase in geriatric population are the major factors boosting the growth of
the global dry eye disease diagnostics & treatment market. Technical
advancements in diagnostic tools and promising pipeline products for dry eye
treatment also fuel the growth of the global dry eye disease diagnostics &
treatment market. For instance, in Japan, decreased tear film stability is
regarded as the core mechanism of dry eye. Hence, dry eye is treated from the
aspect of improving the tear film stability. This therapeutic approach has been
increasing in importance due to the introduction of ophthalmic solutions that
stimulate the secretion of mucin and water. Moreover, adverse effects of rising
pollution levels, surge in use of electronics, and increase in number of laser
in-situ keratomileusis (LASIK) surgeries are the other factors contributing to
the growth of the global dry eye disease diagnostics & treatment market.
Request a
Sample of Dry Eye Disease Diagnostics & Treatment Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=78437
Treatment Preferred over
Diagnostic Tests Due to Approval of Novel Treatments
In terms of type, the global dry eye disease diagnostics &
treatment market has been bifurcated into diagnostic test and treatment. The
treatment segment accounted for major market share in 2019 due
to large pool of pipeline products for dry eye disease treatment, high number
of dry eye patients, and approval of novel treatment approaches in recent
years. The diagnostic test segment has been split into Schirmer’s test, corneal
staining, tear break-up time (TBUT), optical coherence topography (OCT), tear
film stability analysis, tear osmolarity, and others. The treatment segment has
been segregated into artificial tears, anti-inflammatory, punctual plugs,
secretagogue, and others. The artificial tears sub-segment accounted for a
major share of the treatment segment in 2019, as it is the
most commonly prescribed drug forms in ophthalmology. The anti-inflammatory
sub-segment has been divided into cyclosporine, corticosteroids, and others.
Evaporative Dry Eye Syndrome to be
Major Disease Type
Based on disease, the global dry eye disease diagnostics &
treatment market has been classified into evaporative dry eye syndrome and
aqueous dry eye syndrome. The evaporative dry eye syndrome segment dominated
the global dry eye disease diagnostics & treatment market in 2019.
The evaporative dry eye syndrome is projected to be a highly lucrative segment
during the forecast period. The segment is anticipated to expand at a higher
CAGR from 2020 to 2030,
owing to large number of patients, easy access to treatment products, and
changing lifestyle habits, which cause evaporative dry eye syndrome.
Request for
Analysis of COVID19 Impact on Dry Eye Disease Diagnostics & Treatment
Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78437
North America to Dominate Global
Market
In terms of region, the global dry eye disease diagnostics &
treatment market has been divided into North America, Europe, Asia Pacific,
Latin America, and Middle East & Africa. North America accounted for a
major share of the global dry eye disease diagnostics & treatment market
in 2019,
owing to rise in the number of prescriptions for dry eye treatment, favorable
reimbursement scenario for diagnostic tests of dry eye disease, high prevalence
of dry eye disorders, and approval of branded products by major players. The
prevalence of dry eye increases with age. In the U.S., around 98
million people are aged above 50. Therefore, the chances
of an increase in the cases of glaucoma in the U.S. are higher. The market in
Asia Pacific is expected to expand at a high CAGR during the forecast period,
owing to rise in prevalence & incidence of dry eye syndrome, increase in
geriatric population, surge in number of eye care centers leading to increased
product utilization, rise in air pollutant levels, and increase in awareness
about dry eye disease.
Purchase Dry
Eye Disease Diagnostics & Treatment Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=78437<ype=S
Competition Landscape
The global dry eye disease diagnostics & treatment market is
fragmented in terms of number of players, with entry of several new players in
services sector. Key players in the global market include Novartis AG,
Allergan plc, OASIS Medical, Santen Pharmaceutical Co., Ltd., Johnson &
Johnson, Otsuka Pharmaceutical Co., Ltd., Sentiss Pharma Pvt. Ltd., Tomey
Corporation, Carl Zeiss Meditec AG, TearLab Corporation, Bausch Health
Companies, Inc., and RegeneRx (ReGenTree, LLC). Mergers, acquisitions
& strategic collaborations, increased research & development
expenditure, expansion of distribution channels, and new product &
technology launch are major strategies adopted by major companies in the global
dry eye disease diagnostics & treatment market.
More
Trending Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/global-customized-procedure-trays-market-to-grow-as-the-medical-industry-acquires-research-excellence-says-tmr-301210766.html
https://www.prnewswire.com/news-releases/technological-strides-in-bladder-scanners-market-help-clinicians-advance-care-for-patients-with-urinary-tract-infections-valuation-to-touch-mark-of-us-210-0-mn-by-2026-tmr-301213972.html
About Us
Transparency Market Research is a global market intelligence
company providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. Our experienced team
of analysts, researchers, and consultants use proprietary data sources and
various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team
of research experts so that it always reflects latest trends and information.
With a broad research and analysis capability, Transparency Market Research
employs rigorous primary and secondary research techniques in developing
distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
